What happens after complete withdrawal of therapy in patients with lupus nephritis
Clicks: 502
ID: 111790
1970
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
74.9
/100
502 views
342 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 12 articles by views in Clinical and experimental rheumatology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Complete withdrawal of therapy is feasible in selected patients who achieved stable remission after long-term treatment. The reduction of treatment must be done in a very gradual manner, progressively and under strict medical surveillance. The withdrawal of therapy allows the patients to reduce rena …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (44 words).
Try re-searching for a better abstract.
| Reference Key |
g1970clinicalwhat
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Moroni G;Longhi S;Giglio E;Messa P;Ponticelli C;; |
| Journal | Clinical and experimental rheumatology |
| Year | 1970 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
adult
female
male
young adult
Drug Administration Schedule
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Recurrence
Remission Induction
risk factors
chi-square distribution
time factors
drug therapy
combination
pmid:24129143
gabriella moroni
selena longhi
claudio ponticelli
lupus nephritis / diagnosis
lupus nephritis / drug therapy*
lupus nephritis / immunology
patient selection
steroids / administration & dosage*
steroids / adverse effects
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.